"Collagen Type I" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The most common form of fibrillar collagen. It is a major constituent of bone (BONE AND BONES) and SKIN and consists of a heterotrimer of two alpha1(I) and one alpha2(I) chains.
| Descriptor ID |
D024042
|
| MeSH Number(s) |
D05.750.078.280.300.100 D12.776.860.300.250.300.100
|
| Concept/Terms |
Collagen Type I- Collagen Type I
- Type I Collagen
- Collagen, Type I
- Type 1 Collagen
- Collagen, Type 1
|
Below are MeSH descriptors whose meaning is more general than "Collagen Type I".
Below are MeSH descriptors whose meaning is more specific than "Collagen Type I".
This graph shows the total number of publications written about "Collagen Type I" by people in this website by year, and whether "Collagen Type I" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 1 | 1 |
| 2004 | 0 | 2 | 2 |
| 2005 | 1 | 2 | 3 |
| 2006 | 1 | 3 | 4 |
| 2007 | 1 | 2 | 3 |
| 2008 | 1 | 0 | 1 |
| 2010 | 1 | 3 | 4 |
| 2011 | 1 | 2 | 3 |
| 2012 | 2 | 3 | 5 |
| 2013 | 0 | 4 | 4 |
| 2014 | 3 | 3 | 6 |
| 2015 | 0 | 7 | 7 |
| 2016 | 2 | 2 | 4 |
| 2017 | 1 | 5 | 6 |
| 2018 | 1 | 4 | 5 |
| 2019 | 1 | 2 | 3 |
| 2020 | 1 | 4 | 5 |
| 2021 | 0 | 5 | 5 |
| 2022 | 1 | 2 | 3 |
| 2023 | 0 | 2 | 2 |
| 2024 | 1 | 1 | 2 |
| 2025 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Collagen Type I" by people in Profiles.
-
Anti-transforming growth factor-? treatment shows increased bone mass and strength in a novel mouse model for osteogenesis imperfecta type I. J Bone Miner Res. 2025 Jun 25; 40(7):881-890.
-
Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International Osteoporosis Foundation (IOF), and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). Osteoporos Int. 2025 Apr; 36(4):579-608.
-
Collagen-targeted protein nanomicelles for the imaging of non-alcoholic steatohepatitis. Acta Biomater. 2024 10 01; 187:291-303.
-
Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 randomized controlled trial. Nat Med. 2024 Sep; 30(9):2605-2612.
-
Cranio-cervical abnormalities in moderate-to-severe osteogenesis imperfecta - Genotypic and phenotypic determinants. Orthod Craniofac Res. 2024 Apr; 27(2):237-243.
-
Cell Adhesion and Initial Bone Matrix Deposition on Titanium-Based Implants with Chitosan-Collagen Coatings: An In Vitro Study. Int J Mol Sci. 2023 Mar 02; 24(5).
-
Circulating osteogenic progenitors and osteoclast precursors are associated with long-term glycemic control, sex steroids, and visceral adipose tissue in men with type 2 diabetes mellitus. Front Endocrinol (Lausanne). 2022; 13:936159.
-
Lysyl hydroxylase 2 mediated collagen post-translational modifications and functional outcomes. Sci Rep. 2022 08 22; 12(1):14256.
-
Oncogenic collagen I homotrimers from cancer cells bind to a3?1 integrin and impact tumor microbiome and immunity to promote pancreatic cancer. Cancer Cell. 2022 08 08; 40(8):818-834.e9.
-
Dermal aSMA+ myofibroblasts orchestrate skin wound repair via ?1 integrin and independent of type I collagen production. EMBO J. 2022 04 04; 41(7):e109470.